<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Fri, 17 Apr 2026 23:27:14 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/ceritinib/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Noxalk Ceritinib in Natco, India, is only 5% of the price in the United States.]]></title><description><![CDATA[Ceritinib (trade name Zykadia ) is a prescription-only drug used for the treatment non-small cell lung cancer (NSCLC). It was developed by Novartis and received FDA approval for use in April 2014. Zykadia]]></description><link>http://direct.ecency.com/ceritinib/@wonzr/noxalk-ceritinib-in-natco-india-is-only-5-of-the-price-in-the-united-states</link><guid isPermaLink="true">http://direct.ecency.com/ceritinib/@wonzr/noxalk-ceritinib-in-natco-india-is-only-5-of-the-price-in-the-united-states</guid><category><![CDATA[ceritinib]]></category><dc:creator><![CDATA[wonzr]]></dc:creator><pubDate>Fri, 21 Jun 2019 12:22:54 GMT</pubDate><enclosure url="https://images.ecency.com/p/qjrE4yyfw5pEPvDbJDzhdNXM7mjt1tbr2kM3X28F6SraZdLJL3dC7e1tcrpKnup96oUAoiK2UAk6ufdHUhoH9WMkX9PTRsVmVqBn7KH1qEE4QsTtfUks3EGW?format=match&amp;mode=fit" length="0" type="false"/></item></channel></rss>